Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin T King

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Brachytherapy|January 15, 2019
Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapyMartin T King, Paul L Nguyen, Ninjin Boldbaatar, et al.
Cancer|August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medical Physics|September 4, 2023
Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapyMartin T King, Christopher E Kehayias, Tafadzwa Chaunzwa, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 27, 2021
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samplesShuk On Annie Leung, Sarah Feldman, Rajeshwari Kalyanaraman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Brachytherapy|January 15, 2019
Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapyMartin T King, Paul L Nguyen, Ninjin Boldbaatar, et al.
Cancer|August 24, 2017
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medical Physics|September 4, 2023
Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapyMartin T King, Christopher E Kehayias, Tafadzwa Chaunzwa, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 27, 2021
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samplesShuk On Annie Leung, Sarah Feldman, Rajeshwari Kalyanaraman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
Pageof 7